nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Etoposide—testicular cancer	0.161	0.212	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—testicular cancer	0.11	0.144	CbGbCtD
Tenofovir—ABCC10—Methotrexate—testicular cancer	0.106	0.14	CbGbCtD
Tenofovir—ABCC2—Carboplatin—testicular cancer	0.0548	0.0721	CbGbCtD
Tenofovir—ABCC4—Methotrexate—testicular cancer	0.0511	0.0672	CbGbCtD
Tenofovir—ABCC2—Vinblastine—testicular cancer	0.0511	0.0672	CbGbCtD
Tenofovir—ABCC2—Cisplatin—testicular cancer	0.0468	0.0616	CbGbCtD
Tenofovir—ABCC2—Etoposide—testicular cancer	0.046	0.0605	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—testicular cancer	0.0319	0.042	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—testicular cancer	0.0314	0.0413	CbGbCtD
Tenofovir—ABCC2—Methotrexate—testicular cancer	0.0304	0.04	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—testicular cancer	0.0222	0.0293	CbGbCtD
Tenofovir—CYP1A2—Etoposide—testicular cancer	0.0172	0.0226	CbGbCtD
Tenofovir—NME2—embryo—testicular cancer	0.00519	0.0841	CbGeAlD
Tenofovir—AK4—seminal vesicle—testicular cancer	0.00499	0.0808	CbGeAlD
Tenofovir—AK2—female gonad—testicular cancer	0.00396	0.0642	CbGeAlD
Tenofovir—AK4—gonad—testicular cancer	0.00361	0.0584	CbGeAlD
Tenofovir—AK2—testis—testicular cancer	0.00351	0.0569	CbGeAlD
Tenofovir—NME1-NME2—lymph node—testicular cancer	0.00336	0.0544	CbGeAlD
Tenofovir—NME1—female gonad—testicular cancer	0.00304	0.0492	CbGeAlD
Tenofovir—AK4—female gonad—testicular cancer	0.00293	0.0475	CbGeAlD
Tenofovir—NME2—female gonad—testicular cancer	0.00286	0.0464	CbGeAlD
Tenofovir—NME1—testis—testicular cancer	0.0027	0.0437	CbGeAlD
Tenofovir—AK4—testis—testicular cancer	0.0026	0.0421	CbGeAlD
Tenofovir—AK2—lymph node—testicular cancer	0.00255	0.0412	CbGeAlD
Tenofovir—NME2—testis—testicular cancer	0.00254	0.0411	CbGeAlD
Tenofovir—ABCC10—seminal vesicle—testicular cancer	0.00237	0.0383	CbGeAlD
Tenofovir—NME1—lymph node—testicular cancer	0.00196	0.0317	CbGeAlD
Tenofovir—AK4—lymph node—testicular cancer	0.00188	0.0305	CbGeAlD
Tenofovir—NME2—lymph node—testicular cancer	0.00184	0.0298	CbGeAlD
Tenofovir—ABCC10—gonad—testicular cancer	0.00171	0.0277	CbGeAlD
Tenofovir—ABCC10—female gonad—testicular cancer	0.00139	0.0225	CbGeAlD
Tenofovir—ABCC10—testis—testicular cancer	0.00123	0.02	CbGeAlD
Tenofovir—ABCC4—female gonad—testicular cancer	0.00115	0.0187	CbGeAlD
Tenofovir—ABCC4—testis—testicular cancer	0.00102	0.0166	CbGeAlD
Tenofovir—ABCC2—testis—testicular cancer	0.00099	0.016	CbGeAlD
Tenofovir—ABCC10—lymph node—testicular cancer	0.000894	0.0145	CbGeAlD
Tenofovir—ABCC4—lymph node—testicular cancer	0.000741	0.012	CbGeAlD
Tenofovir—ABCC2—lymph node—testicular cancer	0.000718	0.0116	CbGeAlD
Tenofovir—Renal impairment—Epirubicin—testicular cancer	0.000342	0.00192	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—testicular cancer	0.00034	0.00191	CcSEcCtD
Tenofovir—Back pain—Etoposide—testicular cancer	0.000338	0.0019	CcSEcCtD
Tenofovir—Pain—Dactinomycin—testicular cancer	0.000337	0.00189	CcSEcCtD
Tenofovir—Body temperature increased—Bleomycin—testicular cancer	0.000334	0.00188	CcSEcCtD
Tenofovir—Dizziness—Vinblastine—testicular cancer	0.000331	0.00186	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000329	0.00185	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—testicular cancer	0.000326	0.00183	CcSEcCtD
Tenofovir—Myalgia—Cisplatin—testicular cancer	0.000325	0.00183	CcSEcCtD
Tenofovir—Nausea—Chlorambucil—testicular cancer	0.000325	0.00182	CcSEcCtD
Tenofovir—Anxiety—Cisplatin—testicular cancer	0.000324	0.00182	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000323	0.00181	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000323	0.00181	CcSEcCtD
Tenofovir—Dyspnoea—Ifosfamide—testicular cancer	0.000322	0.00181	CcSEcCtD
Tenofovir—Vomiting—Vinblastine—testicular cancer	0.000318	0.00179	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—testicular cancer	0.000317	0.00178	CcSEcCtD
Tenofovir—Decreased appetite—Ifosfamide—testicular cancer	0.000314	0.00176	CcSEcCtD
Tenofovir—Headache—Vinblastine—testicular cancer	0.000314	0.00176	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000312	0.00175	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—testicular cancer	0.000312	0.00175	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—testicular cancer	0.000312	0.00175	CcSEcCtD
Tenofovir—Fatigue—Ifosfamide—testicular cancer	0.000312	0.00175	CcSEcCtD
Tenofovir—Hypersensitivity—Bleomycin—testicular cancer	0.000312	0.00175	CcSEcCtD
Tenofovir—Pain—Ifosfamide—testicular cancer	0.000309	0.00174	CcSEcCtD
Tenofovir—Nervous system disorder—Cisplatin—testicular cancer	0.000306	0.00172	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—testicular cancer	0.000305	0.00171	CcSEcCtD
Tenofovir—Asthenia—Bleomycin—testicular cancer	0.000303	0.0017	CcSEcCtD
Tenofovir—Skin disorder—Cisplatin—testicular cancer	0.000303	0.0017	CcSEcCtD
Tenofovir—Hyperhidrosis—Cisplatin—testicular cancer	0.000301	0.00169	CcSEcCtD
Tenofovir—Pruritus—Bleomycin—testicular cancer	0.000299	0.00168	CcSEcCtD
Tenofovir—Chest pain—Etoposide—testicular cancer	0.000298	0.00167	CcSEcCtD
Tenofovir—Nausea—Vinblastine—testicular cancer	0.000297	0.00167	CcSEcCtD
Tenofovir—Anorexia—Cisplatin—testicular cancer	0.000297	0.00167	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—testicular cancer	0.000296	0.00166	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000296	0.00166	CcSEcCtD
Tenofovir—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000296	0.00166	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—testicular cancer	0.000295	0.00166	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—testicular cancer	0.000291	0.00164	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—testicular cancer	0.000291	0.00163	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—testicular cancer	0.000287	0.00161	CcSEcCtD
Tenofovir—Abdominal pain—Ifosfamide—testicular cancer	0.000286	0.0016	CcSEcCtD
Tenofovir—Body temperature increased—Ifosfamide—testicular cancer	0.000286	0.0016	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000284	0.00159	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—testicular cancer	0.000283	0.00159	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—testicular cancer	0.000282	0.00159	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000279	0.00157	CcSEcCtD
Tenofovir—Dyspnoea—Cisplatin—testicular cancer	0.000278	0.00156	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—testicular cancer	0.000277	0.00156	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—testicular cancer	0.000276	0.00155	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—testicular cancer	0.000276	0.00155	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—testicular cancer	0.000274	0.00154	CcSEcCtD
Tenofovir—Anorexia—Etoposide—testicular cancer	0.000272	0.00153	CcSEcCtD
Tenofovir—Decreased appetite—Cisplatin—testicular cancer	0.000271	0.00152	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—testicular cancer	0.00027	0.00152	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—testicular cancer	0.00027	0.00151	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—testicular cancer	0.000269	0.00151	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000269	0.00151	CcSEcCtD
Tenofovir—Vomiting—Bleomycin—testicular cancer	0.000269	0.00151	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—testicular cancer	0.000268	0.00151	CcSEcCtD
Tenofovir—Infestation—Methotrexate—testicular cancer	0.000268	0.00151	CcSEcCtD
Tenofovir—Depression—Methotrexate—testicular cancer	0.000267	0.0015	CcSEcCtD
Tenofovir—Rash—Bleomycin—testicular cancer	0.000267	0.0015	CcSEcCtD
Tenofovir—Pain—Cisplatin—testicular cancer	0.000266	0.0015	CcSEcCtD
Tenofovir—Dermatitis—Bleomycin—testicular cancer	0.000266	0.0015	CcSEcCtD
Tenofovir—Hypersensitivity—Ifosfamide—testicular cancer	0.000266	0.0015	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—testicular cancer	0.000266	0.00149	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—testicular cancer	0.000264	0.00148	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000262	0.00147	CcSEcCtD
Tenofovir—Asthenia—Ifosfamide—testicular cancer	0.000259	0.00146	CcSEcCtD
Tenofovir—Sweating—Methotrexate—testicular cancer	0.000257	0.00144	CcSEcCtD
Tenofovir—Pruritus—Ifosfamide—testicular cancer	0.000256	0.00144	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—testicular cancer	0.000256	0.00144	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—testicular cancer	0.000255	0.00143	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—testicular cancer	0.000255	0.00143	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—testicular cancer	0.000255	0.00143	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—testicular cancer	0.000254	0.00143	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—testicular cancer	0.000254	0.00142	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—testicular cancer	0.000252	0.00142	CcSEcCtD
Tenofovir—Nausea—Bleomycin—testicular cancer	0.000251	0.00141	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—testicular cancer	0.000251	0.00141	CcSEcCtD
Tenofovir—Infestation—Epirubicin—testicular cancer	0.000251	0.00141	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—testicular cancer	0.000251	0.00141	CcSEcCtD
Tenofovir—Rash—Dactinomycin—testicular cancer	0.000249	0.0014	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—testicular cancer	0.000248	0.00139	CcSEcCtD
Tenofovir—Diarrhoea—Ifosfamide—testicular cancer	0.000247	0.00139	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—testicular cancer	0.000247	0.00139	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—testicular cancer	0.000246	0.00138	CcSEcCtD
Tenofovir—Body temperature increased—Cisplatin—testicular cancer	0.000246	0.00138	CcSEcCtD
Tenofovir—Fatigue—Etoposide—testicular cancer	0.000246	0.00138	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—testicular cancer	0.000246	0.00138	CcSEcCtD
Tenofovir—Pain—Etoposide—testicular cancer	0.000244	0.00137	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000242	0.00136	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—testicular cancer	0.000241	0.00135	CcSEcCtD
Tenofovir—Sweating—Epirubicin—testicular cancer	0.000241	0.00135	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—testicular cancer	0.000239	0.00134	CcSEcCtD
Tenofovir—Dizziness—Ifosfamide—testicular cancer	0.000239	0.00134	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—testicular cancer	0.000238	0.00134	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—testicular cancer	0.000237	0.00133	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—testicular cancer	0.000236	0.00133	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—testicular cancer	0.000236	0.00132	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—testicular cancer	0.000235	0.00132	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—testicular cancer	0.000235	0.00132	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—testicular cancer	0.000234	0.00132	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—testicular cancer	0.000234	0.00131	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—testicular cancer	0.000233	0.00131	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—testicular cancer	0.000232	0.0013	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—testicular cancer	0.000232	0.0013	CcSEcCtD
Tenofovir—Vomiting—Ifosfamide—testicular cancer	0.00023	0.00129	CcSEcCtD
Tenofovir—Hypersensitivity—Cisplatin—testicular cancer	0.00023	0.00129	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—testicular cancer	0.000228	0.00128	CcSEcCtD
Tenofovir—Rash—Ifosfamide—testicular cancer	0.000228	0.00128	CcSEcCtD
Tenofovir—Dermatitis—Ifosfamide—testicular cancer	0.000228	0.00128	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000228	0.00128	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—testicular cancer	0.000226	0.00127	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—testicular cancer	0.000226	0.00127	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—testicular cancer	0.000225	0.00127	CcSEcCtD
Tenofovir—Asthenia—Cisplatin—testicular cancer	0.000224	0.00126	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—testicular cancer	0.000223	0.00125	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—testicular cancer	0.000222	0.00125	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—testicular cancer	0.000221	0.00124	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—testicular cancer	0.000221	0.00124	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—testicular cancer	0.000221	0.00124	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00022	0.00123	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—testicular cancer	0.000218	0.00122	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—testicular cancer	0.000217	0.00122	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—testicular cancer	0.000217	0.00122	CcSEcCtD
Tenofovir—Nausea—Ifosfamide—testicular cancer	0.000215	0.00121	CcSEcCtD
Tenofovir—Diarrhoea—Cisplatin—testicular cancer	0.000213	0.0012	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—testicular cancer	0.000211	0.00118	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—testicular cancer	0.00021	0.00118	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—testicular cancer	0.00021	0.00118	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—testicular cancer	0.000208	0.00117	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000206	0.00116	CcSEcCtD
Tenofovir—Asthenia—Etoposide—testicular cancer	0.000205	0.00115	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—testicular cancer	0.000205	0.00115	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—testicular cancer	0.000204	0.00115	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—testicular cancer	0.000203	0.00114	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—testicular cancer	0.000203	0.00114	CcSEcCtD
Tenofovir—Back pain—Methotrexate—testicular cancer	0.000203	0.00114	CcSEcCtD
Tenofovir—Pruritus—Etoposide—testicular cancer	0.000202	0.00113	CcSEcCtD
Tenofovir—Vomiting—Cisplatin—testicular cancer	0.000198	0.00111	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—testicular cancer	0.000197	0.00111	CcSEcCtD
Tenofovir—Rash—Cisplatin—testicular cancer	0.000196	0.0011	CcSEcCtD
Tenofovir—Dermatitis—Cisplatin—testicular cancer	0.000196	0.0011	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—testicular cancer	0.000196	0.0011	CcSEcCtD
Tenofovir—Diarrhoea—Etoposide—testicular cancer	0.000195	0.0011	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—testicular cancer	0.000193	0.00109	CcSEcCtD
Tenofovir—Back pain—Epirubicin—testicular cancer	0.00019	0.00107	CcSEcCtD
Tenofovir—Dizziness—Etoposide—testicular cancer	0.000189	0.00106	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—testicular cancer	0.000188	0.00106	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000188	0.00105	CcSEcCtD
Tenofovir—Nausea—Cisplatin—testicular cancer	0.000185	0.00104	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—testicular cancer	0.000183	0.00103	CcSEcCtD
Tenofovir—Vomiting—Etoposide—testicular cancer	0.000182	0.00102	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—testicular cancer	0.000181	0.00102	CcSEcCtD
Tenofovir—Rash—Etoposide—testicular cancer	0.00018	0.00101	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—testicular cancer	0.00018	0.00101	CcSEcCtD
Tenofovir—Headache—Etoposide—testicular cancer	0.000179	0.001	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—testicular cancer	0.000179	0.001	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—testicular cancer	0.000178	0.001	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—testicular cancer	0.000178	0.001	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—testicular cancer	0.000178	0.001	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000177	0.000995	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—testicular cancer	0.000175	0.000986	CcSEcCtD
Tenofovir—Nausea—Etoposide—testicular cancer	0.00017	0.000952	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—testicular cancer	0.000168	0.000942	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—testicular cancer	0.000167	0.000938	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—testicular cancer	0.000167	0.000938	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—testicular cancer	0.000167	0.000938	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—testicular cancer	0.000166	0.000934	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—testicular cancer	0.000166	0.000933	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000166	0.000931	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—testicular cancer	0.000165	0.000928	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—testicular cancer	0.000163	0.000915	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—testicular cancer	0.000157	0.000881	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000156	0.000875	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—testicular cancer	0.000155	0.000873	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—testicular cancer	0.000155	0.000869	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—testicular cancer	0.000155	0.000869	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—testicular cancer	0.000154	0.000868	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—testicular cancer	0.000154	0.000868	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—testicular cancer	0.000154	0.000868	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—testicular cancer	0.000154	0.000865	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000153	0.000862	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—testicular cancer	0.000153	0.000857	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—testicular cancer	0.000152	0.000856	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—testicular cancer	0.000151	0.000845	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—testicular cancer	0.000149	0.000835	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000148	0.000829	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—testicular cancer	0.000147	0.000828	CcSEcCtD
Tenofovir—Pain—Methotrexate—testicular cancer	0.000146	0.000821	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000146	0.000819	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—testicular cancer	0.000145	0.000816	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—testicular cancer	0.000145	0.000813	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—testicular cancer	0.000144	0.000808	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000143	0.000804	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—testicular cancer	0.000143	0.000801	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—testicular cancer	0.000141	0.000793	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—testicular cancer	0.000141	0.000791	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—testicular cancer	0.00014	0.000785	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—testicular cancer	0.000139	0.000781	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000138	0.000776	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—testicular cancer	0.000138	0.000775	CcSEcCtD
Tenofovir—Pain—Epirubicin—testicular cancer	0.000137	0.000769	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—testicular cancer	0.000135	0.000759	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—testicular cancer	0.000135	0.000759	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000135	0.000758	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—testicular cancer	0.000134	0.000752	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—testicular cancer	0.000132	0.000741	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000131	0.000735	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—testicular cancer	0.00013	0.000732	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—testicular cancer	0.000129	0.000723	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000128	0.000718	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—testicular cancer	0.000128	0.000717	CcSEcCtD
Tenofovir—Pain—Doxorubicin—testicular cancer	0.000127	0.000711	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—testicular cancer	0.000127	0.000711	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—testicular cancer	0.000127	0.000711	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—testicular cancer	0.000126	0.000708	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—testicular cancer	0.000123	0.000689	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000121	0.00068	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—testicular cancer	0.000121	0.00068	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—testicular cancer	0.000118	0.000662	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—testicular cancer	0.000117	0.000657	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—testicular cancer	0.000117	0.000657	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—testicular cancer	0.000117	0.000657	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—testicular cancer	0.000115	0.000645	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—testicular cancer	0.000113	0.000636	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—testicular cancer	0.000113	0.000635	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—testicular cancer	0.000109	0.000615	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—testicular cancer	0.000109	0.000613	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—testicular cancer	0.000109	0.000611	CcSEcCtD
Tenofovir—Rash—Methotrexate—testicular cancer	0.000108	0.000606	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—testicular cancer	0.000108	0.000605	CcSEcCtD
Tenofovir—Headache—Methotrexate—testicular cancer	0.000107	0.000602	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—testicular cancer	0.000106	0.000597	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—testicular cancer	0.000106	0.000594	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—testicular cancer	0.000105	0.000588	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—testicular cancer	0.000102	0.000571	CcSEcCtD
Tenofovir—Nausea—Methotrexate—testicular cancer	0.000102	0.00057	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—testicular cancer	0.000101	0.000569	CcSEcCtD
Tenofovir—Rash—Epirubicin—testicular cancer	0.000101	0.000567	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—testicular cancer	0.000101	0.000566	CcSEcCtD
Tenofovir—Headache—Epirubicin—testicular cancer	0.0001	0.000563	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—testicular cancer	9.79e-05	0.00055	CcSEcCtD
Tenofovir—Nausea—Epirubicin—testicular cancer	9.51e-05	0.000534	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—testicular cancer	9.41e-05	0.000529	CcSEcCtD
Tenofovir—Rash—Doxorubicin—testicular cancer	9.34e-05	0.000524	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—testicular cancer	9.33e-05	0.000524	CcSEcCtD
Tenofovir—Headache—Doxorubicin—testicular cancer	9.28e-05	0.000521	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—testicular cancer	8.8e-05	0.000494	CcSEcCtD
